0.8853
Heartbeam Inc stock is traded at $0.8853, with a volume of 9.06M.
It is down -26.22% in the last 24 hours and down -34.90% over the past month.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
See More
Previous Close:
$1.20
Open:
$0.9
24h Volume:
9.06M
Relative Volume:
7.09
Market Cap:
$36.38M
Revenue:
-
Net Income/Loss:
$-21.02M
P/E Ratio:
-1.4131
EPS:
-0.6265
Net Cash Flow:
$-14.59M
1W Performance:
-25.61%
1M Performance:
-34.90%
6M Performance:
-49.98%
1Y Performance:
-46.35%
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BEAT
Heartbeam Inc
|
0.8853 | 49.31M | 0 | -21.02M | -14.59M | -0.6265 |
|
VEEV
Veeva Systems Inc
|
167.30 | 25.98B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
56.41 | 8.89B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
46.01 | 8.89B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
83.67 | 6.87B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
24.68 | 4.30B | 1.10B | 112.09M | 283.19M | 0.6096 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | B. Riley Securities | Buy |
| Mar-27-26 | Initiated | D. Boral Capital | Buy |
| Mar-16-26 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
HeartBeam (NASDAQ: BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives - USA Today
HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives - NewMediaWire
HeartBeam prices $10M public offering at $0.80 per share By Investing.com - Investing.com Australia
BEAT: Titan Partners Leads Successful Stock Offering - GuruFocus
HeartBeam announces stock offering; shares drop 18% after-hours - MSN
HeartBeam slips 12%, prices $10M stock offering - MSN
HeartBeam’s first customer joins insiders in $10M stock sale - Stock Titan
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock - Business Wire
HeartBeam launches public offering of common stock - Investing.com
HeartBeam launches public offering of common stock By Investing.com - Investing.com India
HeartBeam (NASDAQ: BEAT) seeks funding with [●]‑share offering and pre‑funded warrants - Stock Titan
Heartbeam announces proposed public offering of common stock - marketscreener.com
Heartbeam Announces Proposed Public Offering Of Common Stock - TradingView — Track All Markets
HeartBeam Announces Proposed Public Offering of Common Stock - Business Wire
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 earnings call transcript - MSN
Aug Chart Watch: Will HeartBeam Inc benefit from rising consumer demand2026 Technicals & Verified Momentum Stock Ideas - baoquankhu1.vn
HeartBeam Faces Competitive Landscape as Medical Tech Rivals Vie for Market Share - National Today
Block Trades: Will HeartBeam Inc benefit from rising consumer demand2026 Trade Ideas & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam's (BEAT) 'Significant Turning Point' Spotlighted in Recent Article - NewMediaWire
BEAT Stock Price, Quote & Chart | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
BEAT SEC FilingsHeartbeam Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartBeam’s (NASDAQ: BEAT) ‘Significant Turning Point’ Spotlighted in Recent Article - TradingView — Track All Markets
Sectors Review: Should value investors consider HeartBeam Inc2026 Analyst Calls & Real-Time Volume Analysis Alerts - baoquankhu1.vn
HeartBeam Reaches 'Significant Turning Point' After FDA Clearance - National Today
B. Riley Securities Initiates Coverage on HeartBeam (BEAT) with Buy Rating | BEAT Stock News - GuruFocus
B. Riley Securities Initiates HeartBeam(BEAT.US) With Buy Rating, Announces Target Price $4 - moomoo.com
B.Riley initiates Heartbeam stock coverage with buy rating on FDA clearance - Investing.com
Aug Sentiment: What analysts say about HeartBeam Inc stock2026 Retail Activity & Low Drawdown Trading Strategies - baoquankhu1.vn
D. Boral Capital initiates Heartbeam stock coverage with buy rating By Investing.com - Investing.com India
This Honeywell Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
How Decentralized AI is Unlocking Value in Cardiac Diagnostics - Benzinga
D. Boral Capital initiates Heartbeam stock coverage with buy rating - Investing.com
HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and Validation - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation - Digital Journal
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - USA Today
HeartBeam (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates - USA Today
HeartBeam (BEAT) director receives 44,827-share stock option grant at $1.43 - Stock Titan
HeartBeam (BEAT) CFO receives stock options on 53,104 shares at $1.45 - Stock Titan
HeartBeam (BEAT) awards director Richard Ferrari 50,000 RSUs - Stock Titan
HeartBeam (BEAT) awards 41,380-share stock option grant to major holder - Stock Titan
HeartBeam (BEAT) director awarded 20,689 RSUs, holdings rise to 95,809 shares - Stock Titan
HeartBeam (BEAT) president receives 61,932-share stock option grant at $1.45 - Stock Titan
HeartBeam (BEAT) director receives 51,724 options at $1.43 exercise price - Stock Titan
HeartBeam (BEAT) director receives 17,241 RSUs in equity grant - Stock Titan
Director at HeartBeam (NASDAQ: BEAT) receives option grant for 51,724 shares - Stock Titan
HeartBeam (BEAT) president receives 55,172 stock options as equity grant - Stock Titan
Aug Opening: Can HeartBeam Inc outperform in the next rallyTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
If You Invested $1,000 in Heartbeam Inc (BEAT) - Stock Titan
HeartBeam announces first patient enrollments in heart attack detection pilot study - MSN
HeartBeam : Earnings Documents - MarketScreener
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Heartbeam Inc Stock (BEAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| de Urioste George | Director |
Dec 18 '25 |
Sale |
2.83 |
33,185 |
93,914 |
0 |
| de Urioste George | Director |
Dec 17 '25 |
Sale |
3.68 |
23,961 |
88,176 |
33,185 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):